Integrative Mental Health Care Is Addressing the Limitations of Conventional and CAM Treatments and Current Models of Care

DepressedManAtWindow.jpg

sad young white man with beard standing at window with head bowed and eyes closed

Photo by gstockstudio / 123rf.com

Introduction

High prevalence rates and unmet treatment needs of individuals who struggle with major depressive disorder, bipolar disorder and other serious mental health problems underscore the inadequacies of both conventional treatments and complementary and alternative (CAM) treatments and the limitations of the current model of mental health care. In this post I briefly review the limitations of conventional treatment approaches and CAM treatments of mental health problems. I describe how integrative mental health care will more adequately address mental health care needs through safer, more effective treatment strategies incorporating evidence-based conventional treatments and CAM approaches in the context of a truly integrated model of mental health care delivery in which medical and mental health problems are addressed in outpatient clinic settings.

Limitations of conventional mental health care

Systematic reviews of placebo-controlled studies on widely used psychotropic medications have found marginal effectiveness of many pharmacologic treatments of major depressive disorder, bipolar disorder, and other psychiatric disorders (Kelly 2010; Stafford et al 2011; Hartling et al 2012; Fournier et al 2009; Thase 2007; Velligan et al 2009; Herrmann 2011; Kirsch et al 2008). In addition to concerns about efficacy, many commonly prescribed psychotropic medications including several antidepressants and antipsychotics are associated with serious adverse effects such as weight gain, increased risk of diabetes and heart disease, neurologic disorders, and sudden cardiac death (Henderson 2008). Metabolic syndrome associated with weight gain and increased risk of diabetes and coronary artery disease is a well-documented adverse effect of antipsychotics. Poor treatment outcomes owing to limited efficacy of psychotropic medications result in long-term impairments in functioning, work absenteeism, and losses in productivity (John Eisenberg Center 2016; Barnes 2008; Beck et al 2011; Laxman et al 2008; Barbato 1998).

In addition to the above concerns, the current mainstream model of mental health care is limited by disparities in the delivery of mental health services to different socioeconomic classes and the lack of integration of mental health services into primary care and other medical subspecialties (Cunningham 2009). Numerous studies show that collaborative care models reduce health care disparities in patients from different socioeconomic and ethnic backgrounds (Arean et al 2005; Ell et al 2009; Ell et al 2010; Ell et al) and are more effective than conventional care models for treatment of depressed mood, anxiety disorders, bipolar disorder, and schizophrenia (Unutzer et al 2002; Gilbody 2006; Simon 2009, Reilly et al 2013; Woltmann et al 2012). Both clinician and patients report high levels of satisfaction with the management of depressed mood in collaborative care settings (Levine et al 2005; Unutzer et al 2002). Finally, collaborative care is more cost-effective than usual care in all categories measured, including medication costs and inpatient, outpatient, and mental health specialty care (Unutzer et al 2008), as well as for the management of depressed patients with comorbid medical disorders (Katon et al 2011), severe anxiety disorders (Katon et al 2002), and serious chronic mental illness (Druss et al 2011; Grypma 2005; Reiss-Brennan et al 2010).

The growing relevance of complementary and alternative medicine (CAM) in mental health care

In the context of the limitations of available pharmacologic treatments research is ongoing to identify safe and effective complementary and alternative (CAM) treatments of depressed mood, anxiety, and other mental health problems. Accumulating research findings support that select natural supplements, lifestyle modification such as exercise and maintaining a healthy diet, mind-body and mindfulness approaches such as meditation and yoga have beneficial effects on different mental health problems. Examples include S-adenosyl methionine (SAMe) for depressed mood; omega-3 fatty acids, folic acid (especially its active form l-methyl-folinic acid) as add-ons to antidepressants, the amino acids 5-hydroxytryptophan, and n-acetyl cysteine for mood disorders; a standardized extract of the herbal kava for anxiety disorders; and the amino acid l-theanine also for anxiety disorders (Lake 2017). In addition to natural supplements research findings support the use of acupuncture for generalized anxiety and depressed mood, and mindfulness training for improving anxiety, mood disorders as well as cognitive symptoms that often accompany schizophrenia (Lake 2006).

In addition to discrete treatments that target a specific disorder or symptom pattern, lifestyle modifications such as regular exercise, healthy diet, sufficient sleep, and reducing alcohol and nicotine use also enhance mental and emotional well-being while reducing the relapse risk for many psychiatric disorders (Sarris 2011). CAM approaches are already widely used to treat or self-treat mental health problems. Survey findings show that roughly 1/2 of individuals with an anxiety disorder (Bystritsky et al 2012) or depressed mood (Wu et al 2007) use 1 or more CAM treatments. It is significant that individuals with severe mental illnesses such as major depressive disorder and bipolar disorder who use CAM therapies to treat their symptoms feel strongly that such nonpharmacologic treatments improve their physical, emotional, cognitive, social, and spiritual functioning; reduce the severity of their symptoms; and enhance overall wellness (Sirois 1008). Increasing acceptance of CAM therapies in the US and other economically developed world regions is the result of scientific advances, social trends, and the availability of safe, affordable nonpharmacologic treatments.

Widespread use of CAM by individuals who are concurrently receiving psychotropic medications is driving a trend toward increasingly integrative mental health care in North America, Europe, Australia, and other world regions. Findings of a recent survey (Horrigan 2012) support that integrative treatment strategies incorporating medications and evidence-based CAM therapies are often beneficial for both medical and mental health problems. The same survey pointed to depressed mood and anxiety as among the top 5 health concerns for which CAM and integrative approaches are most beneficial.

The limitations of CAM in mental health care

Although growing acceptance of evidence-based CAM in mental health care is an improvement over available conventional treatments, CAM treatments are not without problems. For example, it is estimated that more than 50% of all individuals with a diagnosis of a mood or anxiety disorder use CAM therapies to manage their symptoms but few disclose CAM use to their psychiatrist, family physician, or other conventional health care practitioners (Thomson 2012). To further complicate matters, many widely used CAM therapies are supported by limited research evidence. In fact, relatively few CAM therapies have been substantiated by consistent positive findings of large, well-designed, placebo-controlled studies. Furthermore, many CAM therapies are limited by incomplete knowledge of their mechanisms of action, small study sizes, inconsistent research findings, and – in some cases – safety concerns. The result is that individuals who use supplements or other CAM therapies not supported by strong research place themselves at risk of disappointing outcomes or potentially serious safety problems (Ernst 2003) when such therapies are used in combination with conventional pharmacologic agents.

The emerging role of integrative mental health care

High prevalence rates and unmet treatment needs of individuals with major depressive disorder, bipolar disorder, schizophrenia and other severe mental illnesses in both developed and less developed countries underscore the inadequacies of both conventional pharmacologic treatments and CAM modalities and the limitations of current models of mental health care. The lack of compelling evidence for many conventional and CAM modalities poses complex challenges for psychiatrists and therapists as well as individuals seeking ‘evidence-based’ treatment(s) for their mental health problem. These circumstances define an urgent agenda for developing effective, safe, and affordable integrative treatment strategies incorporating evidence-based pharmacologic treatments and psychotherapies, and substantiated CAM modalities including select natural supplements, mind-body and mindfulness approaches and others. In equal measure, there is an urgent need to establish a more integrated model of mental health care delivery in which medical and mental health problems are addressed in a single clinic.

The paradigm of integrative medicine has emerged in response both to patients’ needs, providers’ changing perspectives, and the limitations of the current model of care. Integrative medicine affirms the importance of the relationship between practitioner and patient, focuses on the whole person, is informed by research evidence, and goes beyond the limitations of biomedicine or CAM by incorporating diverse treatment approaches with the goals of achieving optimal wellness, preventing relapse, and improving outcomes (Academic Consortium for Integrative Medicine 2017). Integrative mental health care is an important offshoot of integrative medicine that focuses on the whole person rather than a particular disorder. Like integrative medicine, integrative mental health care emphasizes wellness and healthy lifestyle choices while addressing complex biological, psychological, cultural, economic and spiritual or religious factors that affect general well-being and mental health. As such, integrative mental health care is an evidence-based, research-driven paradigm that acknowledges the legitimacy of conventional and CAM treatments and recommends specific treatment combinations supported by research findings. The reader is referred to Lake et al 2012 (Lake et al 2012) for a more detailed discussion of the foundations and methods of integrative mental health care. A model of care that incorporates evidence-based conventional and CAM modalities into existing models used in outpatient settings will address the limitations of conventional and CAM treatments, resulting in improved outcomes, increased patient satisfaction, and reduced costs.

References

Academic Consortium for Integrative Medicine & Health homepage [Internet]. McLean, VA: Academic Consortium for Integrative Medicine & Health; 2017

Areán PA, Ayalon L, Hunkeler E, et al. Improving depression care for older, minority patients in primary care. Med Care 2005 Apr;43(4):381-90.

Barbato A. Schizophrenia and public health [Internet]. Geneva, Switzerland: Division of Mental Health and Prevention of Substance Abuse, World Health Organization; 1998

Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008 Dec 10;(12):1-23.

Beck A, Crain AL, Solberg LI, et al. Severity of depression and magnitude of productivity loss. Ann Fam Med 2011 Jul-Aug;9(4):305-11.

Bhui K, Dinos S. Preventive psychiatry: A paradigm to improve population mental health and well-being. Br J Psychiatry 2011 Jun;198(6):417-9.

Bystritsky A, Hovav S, Sherbourne C, et al. Use of complementary and alternative medicine in a large sample of anxiety patients. Psychosomatics 2012 May-Jun;53(3):266-72.

Cunningham PJ. Beyond parity: Primary care physicians’ perspectives on access to mental health care. Health Aff (Millwood) 2009 May-Jun;28(3):w490-501.

Druss BG, von Esenwein SA, Compton MT, Zhao L, Leslie DL. Budget impact and sustainability of medical care management for persons with serious mental illnesses. Am J Psychiatry 2011 Nov;168(11):1171-8.

Ell K, Aranda MP, Xie B, Lee PJ, Chou CP. Collaborative depression treatment in older and younger adults with physical illness: Pooled comparative analysis of three randomized clinical trials. Am J Geriatr Psychiatry 2010 Jun;18(6):520-30.

Ell K, Katon W, Cabassa LJ, et al. Depression and diabetes among low-income Hispanics: Design elements of a socioculturally adapted collaborative care model randomized controlled trial. Int J Psychiatry Med 2009;39(2):113-32.

Ell K, Katon W, Xie B, et al. Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: A randomized controlled trial. Diabetes Care 2010 Apr;33(4):706-13.

Ernst E. Serious psychiatric and neurological adverse effects of herbal medicines—a systematic review. Acta Psychiatr Scand 2003 Aug;108(2):83-91.

Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA 2010 Jan 6;303(1):47-53.

Gilbody S, Bower P, Whitty P. Costs and consequences of enhanced primary care for depression: Systematic review of randomised economic evaluations. Br J Psychiatry 2006 Oct;189:297-308.

Grypma L, Haverkamp R, Little S, Unützer J. Taking an evidence-based model of depression care from research to practice: Making lemonade out of depression. Gen Hosp Psychiatry 2006 Mar-Apr;28(2):101-7.

Hartling L, Abu-Setta AM, Dursun S, Mousavi SS, Pasichnyk D, Newton AS. Antipsychotics in adults with schizophrenia: Comparative effectiveness of first-generation versus second-generation medications: A systematic review and meta-analysis. Ann Intern Med 2012 Oct 2;157(7):498-511.

Henderson DC. Managing weight gain and metabolic issues in patients treated with atypical antipsychotics. J Clin Psychiatry 2008 Feb;69(2):e04.

Herrmann N, Chau SA, Kircanski I, Lanctôt KL. Current and emerging drug treatment options for Alzheimer’s disease: A systematic review. Drugs 2011 Oct 22;71(15):2031-65.

Horrigan B, Lewis S, Abrams D, Pechura C. Integrative medicine in America: How integrative medicine is being practiced in clinical centers across the United States. Tucson, AZ: The Bravewell Collaborative; 2012 Feb.

John M Eisenberg Center for Clinical Decisions and Communications Science. Nonpharmacological versus pharmacological treatment for patients with major depressive disorder: Current state of the evidence [Internet]. Rockville, MD: Agency for Healthcare Research and Quality; 2016 Sep 13

Katon W, Russo J, Lin EH, et al. Cost-effectiveness of a multicondition collaborative care intervention: A randomized controlled trial. Arch Gen Psychiatry 2012 May;69(5):506-14.

Katon WJ, Roy-Byrne P, Russo J, Cowley D. Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Arch Gen Psychiatry 2002 Dec;59(12):1098-104.

Kelley J. (2 March 2010) Antidepressants: Do they “work” or don't they? [Internet]. New York, NY: Scientific American; 2010 Mar 2

Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008 Feb;5(2):e45.

Lake J. Textbook of integrative mental health care. New York, NY: Thieme Medical Publishers; 2006.

Lake JH. Chapter 31.4: Complementary, alternative, and integrative approaches in mental health care. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry. 10th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2017. p 2532-54.

Laxman KE, Lovibond KS, Hassan MK, et al. Impact of bipolar disorder in employed populations. Am J Manag Care 2008 Nov;14(11):757-64.

Levine S, Unützer J, Yip JY, et al. Physicians’ satisfaction with a collaborative disease management program for late-life depression in primary care. Gen Hosp Psychiatry 2005 Nov-Dec;27(6):383-91.

Reilly S, Planner C, Gask L, et al. Collaborative care approaches for people with severe mental illness. Cochrane Database Syst Rev 2013 Nov 4;(11):CD009531.

Reiss-Brennan B, Briot PC, Savitz LA, Cannon W, Staheli R. Cost and quality impact of Intermountain’s mental health integration program. J Healthc Manag 2010 Mar-Apr;55(2):97-113.

Sarris J. Clinical depression: An evidence-based integrative complementary medicine treatment model. Altern Ther Health Med 2011 Jul-Aug;17(4):26-37.

Simon G. Collaborative care for mood disorders. Curr Opin Psychiatry 2009 Jan;22(1):37-41.

Sirois FM. Motivations for consulting complementary and alternative medicine practitioners: A comparison of consumers from 1997-8 and 2005. BMC Complement Altern Med 2008 Apr;8(16).

Stafford MR, Mayo-Wilson E, Loucas CE, et al. Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: A systematic review and meta-analysis. PloS One Feb 11;10(2):e0117166.

Thase ME. STEP-BD and bipolar depression: What have we learned? Curr Psychiatry Rep 2007 Dec;9(6):497-503.

Thomson P, Jones J, Evans JM, Leslie SL. Factors influencing the use of complementary and alternative medicine and whether patients inform their primary care physician. Complement Ther Med 2012 Feb-Apr;20(1-2):45-53.

Unützer J, Katon W, Callahan CM, et al; IMPACT Investigators. Collaborative care management of late-life depression in the primary care setting: A randomized controlled trial. JAMA 2002 Dec 11;288(22):2836-45.

Unutzer J, Katon WJ, Fan MY, et al. Long-term cost effects of collaborative care for late-life depression. Am J Manag Care 2008 Feb;14(2):95-100.

Velligan DI, Weiden PJ, Sajatovic M, et al; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009;70 Suppl 4:1-46.

Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: Systematic review and meta-analysis. Am J Psychiatry 2012 Aug;169(8):790-804.

Wu P, Fuller C, Liu X, et al. Use of complementary and alternative medicine among women with depression: Results of a national survey. Psychiatr Serv 2007 Mar;58(3):349-56.

About the Author

James Lake

James Lake, M.D., is a Board-certified psychiatrist who practices on the central California coast. He has chaired symposia and workshops at APA meetings and other national and international conferences on complementary, alternative and integrative mental health care.

He has served as a clinical assistant professor of psychiatry at Stanford and